Principales publications:
Resilience of patients with skin diseases in France: A cross-sectional study. Halioua B, Patras de Campaigno C, Merhand S, Charles B, Bru MF, Legrand C, Beausillon C, Raynal H, Taieb C, Richard MA. J Eur Acad Dermatol Venereol. 2022
Prevalence of visible skin diseases: An international study of 13,138 people.
Cribier B, Aroman MS, Merhand S, Aubert R, Audouze A, Legrand C, Carre M, Raynal H, Baissac C, Taieb C, Richard MA.J Eur Acad Dermatol Venereol. 2022
Treatment with a retinoic acid-inducible gene I (RIG-I) agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: results from two phase 1 studies. Moreno V, Calvo E, Middleton MR, Barlesi F, Gaudy-Marqueste C, Italiano A, Romano E, Marabelle A, Chartash E, Dobrenkov K, Zhou H, Connors EC, Zhang Y, Wermke M. Cancer Immunol Immunother. 2022
Biologics combined with conventional systemic agents for the treatment of children with severe psoriasis. Real-life data from the BiPe cohorts and a practice survey among French and Italian pediatric dermatologists. Mahé E, Beauchet A, Hadj-Rabia S, Mazereeuw-Hautier J, Mallet S, Phan A, Severino-Freire M, Boralevi F, Aubert H, Barthélémy H, Girard C, Martin L, Piram M, Barbarot S, Balguerie X, Zitouni J, Phan C, Di Lernia V; Groupe de Recherche sur le Psoriasis (GrPso) of the Société Française de Dermatologie (SFD), Groupe de Recherche de la Société Française de Dermatologie Pédiatrique (GR SFDP), and Società Italiana di Dermatologia Pediatrica (S.I.Der.P.).Dermatol Ther. 2022
Moderate Psoriasis in Clinical Practice: French Expert Consensus Using a Modified Delphi Method. Richard MA, Aubin F, Beneton N, Bouloc A, Bursztejn AC, Descamps V, Jullien D. Adv Ther. 2022
Switches between biologics in patients with moderate-to-severe psoriasis: results from the French cohort PSOBIOTEQ. Curmin R, Guillo S, De Rycke Y, Bachelez H, Beylot-Barry M, Beneton N, Chosidow O, Dupuy A, Joly P, Jullien D, Richard MA, Viguier M, Sbidian E, Paul C, Mahé E, Tubach F; PSOBIOTEQ Study Group. J Eur Acad Dermatol Venereol. 2022
Effectiveness and safety of dupilumab in the treatment of atopic dermatitis in children (6-11 years): data from a French multicentre retrospective cohort in daily practice. Lasek A, Bellon N, Mallet S, Puzenat E, Bursztejn AC, Abasq C, Mazereeuw-Hautier J, Chiaverini C, Hubiche T, Raison Peyron N, Du Thanh A, Barbarot S, Aubert H, Reguiai Z, Droitcourt C, Fievet C, Bellissen A, Bachelerie M, Nosbaum A, Leymarie A, Armingaud P, Masson Regnault M, Mahé E; Research Group of the Société Française de Dermatologie Pédiatrique (GR SFDP); Research Group of eczéma atopique (GREAT). J Eur Acad Dermatol Venereol. 2022
Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma. Yurchenko AA, Pop OT, Ighilahriz M, Padioleau I, Rajabi F, Sharpe HJ, Poulalhon N, Dreno B, Khammari A, Delord M, Alberti A, Soufir N, Battistella M, Mourah S, Bouquet F, Savina A, Besse A, Mendez-Lopez M, Grange F, Monestier S, Mortier L, Meyer N, Dutriaux C, Robert C, Saiag P, Herms F, Lambert J, de Sauvage FJ, Dumaz N, Flatz L, Basset-Seguin N, Nikolaev SI.Clin Cancer Res. 2022
Patient Perception of the Diagnosis Announcement and its Impact on Quality of Life of Patients with Primary Melanoma or Basal Cell Carcinoma. Aymonier M, Taieb C, Corgibet F, Joly P, Sei JF, Chaussade V, Philippe C, Ezzedine K, Richard MA. Acta Derm Venereol. 2022
Molecular characterization of fast-growing melanomas. Gaudy-Marqueste C, Macagno N, Loundou A, Pellegrino E, Ouafik L, Budden T, Mundra P, Gremel G, Akhras V, Lin L, Cook M, Kumar R, Grob JJ, Nagore E, Marais R, Virós A. J Am Acad Dermatol. 2022
Dermatologic manifestations in paediatric neurofibromatosis type 2: a cross sectional descriptive multicentric study. Legoupil S, Bessis D, Picard F, Mallet S, Mazereeuw J, Phan A, Dupin-Deguine D, Kalamarides M; Research Group of the French Society of Paediatric Dermatology, Chiaverini C. Orphanet J Rare Dis. 2022
Morphological evaluation of melanocytic lesions with three-dimensional line-field confocal optical coherence tomography: correlation with histopathology and reflectance confocal microscopy. A pilot study. Perez-Anker J, Puig S, Alos L, García A, Alejo B, Cinotti E, Orte Cano C, Tognetti L, Lenoir C, Monnier J, Machuca N, Castillo P, Gibert PR, Rubegni P, Suppa M, Perrot JL, Del Marmol V, Malvehy J.Clin Exp Dermatol. 2022
Combined reflectance confocal microscopy and optical coherence tomography to improve the diagnosis of equivocal lesions for basal cell carcinoma. Monnier J, De Carvalho N, Harris U, Garfinkel J, Saud A, Navarrete-Dechent C, Liopyris K, Reiter O, Rubinstien G, Iftimia N, Nehal KS, Markova A, Deng L, Rossi AM, Marghoob AA, Marchetti MA, Rotemberg V, Pellacani G, Jain M. J Am Acad Dermatol. 2022
Methotrexate for idiopathic chronic eczematous eruption of aging. Sarles C, Amatore F, Malissen N, Gaudy-Marqueste C, Grob JJ, Macagno N, Richard MA. Eur J Dermatol. 2021 Dec 1;31(6):839-841.
Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts. Condamina M, Penso L, Tran VT, Hotz C, Guillem P, Villani AP, Perrot P, Bru MF, Jacquet E, Nassif A, Bachelez H, Wolkenstein P, Beylot-Barry M, Richard MA, Ravaud P, Viguier M, Sbidian E. Dermatology. 2021;237(5):748-758.
Position statement on classification of basal cell carcinomas. Part 2: EADO proposal for new operational staging system adapted to basal cell carcinomas.
Grob JJ, Gaudy-Marqueste C, Guminski A, Malvehy J, Basset-Seguin N, Bertrand B, Fernandez-Penas P, Kaufmann R, Zalaudek I, Fargnoli MC, Tagliaferri L, Fertil B, Del Marmol V, Stratigos A, Garbe C, Peris K.J Eur Acad Dermatol Venereol. 2021.
Effectiveness and safety of nivolumab in patients with advanced melanoma: A multicenter, observational study. Monestier S, Dalle S, Mortier L, Dutriaux C, Dalac-Rat S, Meyer N, Leccia MT, Mansard S, Montaudié H, Saiag P, Combemale P, Guillot B, Skowron F, Duval Modeste AB, Bénéton N, Hainaut E, Robert C, Arnault JP, Le Corre Y, Jouary T, Ameur N, Varey E, Khammari A, Dréno B; RIC-Mel network. Int J Cancer. 2021.
Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations. Le Duff F, Bouaziz JD, Fontas E, Ticchioni M, Viguier M, Dereure O, Reygagne P, Montaudié H, Lacour JP, Monestier S, Richard MA, Passeron T.J Invest Dermatol. 2021
Which adjuvant treatment for patients with BRAFV600-mutant cutaneous melanoma? Funck-Brentano E, Malissen N, Roger A, Lebbé C, Deilhes F, Frénard C, Dréno B, Meyer N, Grob JJ, Tétu P, Saiag P.Ann Dermatol Venereol. 2021
Early Phase of Primary Melanoma Growth from the Patient Point of view: A Prospective Cross Sectional Study on Melanoma over 1 mm in Thickness. Malissen N, Abed S, Macagno N, Amatore F, Loundou A, Grange F, Gaudy-Marqueste C, Grob JJ.Acta Derm Venereol. 2020
ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee. Keilholz U, Ascierto PA, Dummer R, Robert C, Lorigan P, van Akkooi A, Arance A, Blank CU, Chiarion Sileni V, Donia M, Faries MB, Gaudy-Marqueste C, Gogas H, Grob JJ, Guckenberger M, Haanen J, Hayes AJ, Hoeller C, Lebbé C, Lugowska I, Mandalà M, Márquez-Rodas I, Nathan P, Neyns B, Olofsson Bagge R, Puig S, Rutkowski P, Schilling B, Sondak VK, Tawbi H, Testori A, Michielin O. Ann Oncol. 2020
Stereotactic radiosurgery combined with anti-PD1 for the management of melanoma brain metastases: A retrospective study of safety and efficacy. Carron R, Gaudy-Marqueste C, Amatore F, Padovani L, Malissen N, Balossier A, Loundou A, Bonnet N, Muracciole X, Régis JM, Grob JJ. Eur J Cancer. 2020
HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma. Malissen N, Macagno N, Granjeaud S, Granier C, Moutardier V, Gaudy-Marqueste C, Habel N, Mandavit M, Guillot B, Pasero C, Tartour E, Ballotti R, Grob JJ, Olive D. Oncoimmunology. 2019
